After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that NGM Bio to Participate in the Cowen 44th Annual Health Care Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $1.92 and fluctuated between $1.9400 as its day high and $1.6300 as its day low. The current market capitalization of Ngm Biopharmaceuticals Inc is $158.82M. A total of 1.36 million shares were traded on the day, compared to an average of 994.99K shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, NGM has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 11 BUYs and 0 SELLs from insiders. Insiders purchased 418,642 shares during that period but sold 0.
In the most recent transaction, COLUMN GROUP L P bought 5,840 shares of NGM for 0.62 per share on Nov 16. After the transaction, the Director now owns 949,862 company shares. In a previous transaction on Nov 16, COLUMN GROUP L P bought 5,840 shares at 0.62 per share. NGM shares that Director owns now total 949,862.
Among the insiders who bought shares, COLUMN GROUP L P acquired of 5,840 shares on Nov 16 at a per-share price of $0.62. This resulted in the Director holding 949,862 shares of NGM after the transaction. In another insider transaction, GOEDDEL DAVID V bought 5,840 shares at $0.62 per share on Nov 16. Company shares held by the Director now total 949,862.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for NGM in the last 3 months, the mean price target is $4.70 with high estimates of $6.00 and low estimates of $3.50. In terms of 52-week highs and lows, NGM has a high of $4.84 and a low of $0.60.
As of this writing, NGM has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.66. The company reported an EPS of -$0.46 in the last quarter, which was 8.00% higher than expectations of -$0.5.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NGM’s latest balance sheet shows that the firm has $366.25M in Cash & Short Term Investments as of fiscal 2021. There were $10.46M in debt and $61.35M in liabilities at the time. Its Book Value Per Share was $2.05, while its Total Shareholder’s Equity was $335.65M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NGM is Buy with a score of 4.17.
